Contribution of microRNA-30d to the prevention of the thyroid cancer occurrence and progression: mechanism and implications

Lin JD, Liou MJ, Hsu HL, Leong KK, Chen YT, Wang YR, Hung WS, Lee HY, Tsai HJ, Tseng CP (2018) Circulating epithelial cell characterization and correlation with remission and survival in patients with thyroid Cancer. Thyroid 28(11):1479–1489

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

Raue F, Frank-Raue K (2016) Thyroid Cancer: risk-stratified management and individualized therapy. Clin Cancer Res 22(20):5012–5021

Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, Papotti MG, Berruti A, [email protected] EGCEa (2019) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol 30(12):1856–1883

Xu X, Long H, Xi B, Ji B, Li Z, Dang Y, Jiang C, Yao Y, Yang J (2019) Molecular Network-Based drug prediction in thyroid Cancer.Int J Mol Sci20(2)

Cao J, Zhang M, Zhang L, Lou J, Zhou F, Fang M (2021) Non-coding RNA in thyroid cancer - functions and mechanisms. Cancer Lett 496:117–126

Borran S, Ahmadi G, Rezaei S, Anari MM, Modabberi M, Azarash Z, Razaviyan J, Derakhshan M, Akhbari M, Mirzaei H (2020) Circular RNAs: New players in thyroid cancer. Pathol Res Pract 216(10):153217

Fuziwara CS, Kimura ET (2017) MicroRNAs in thyroid development, function and tumorigenesis. Mol Cell Endocrinol 45644–50

Pallante P, Battista S, Pierantoni GM, Fusco A (2014) Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol 10(2):88–101

Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L, Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, Ming ZJ, Li B, Chen B, Wang JR, Liu YB, Yang JM (2014) Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin. Biochem Pharmacol 87(4):562–570

Wang H, Li YP, Chen JH, Yuan SF, Wang L, Zhang JL, Yao Q, Li NL, Bian JF, Fan J, Yi J, Ling R (2013) Prognostic significance of USP22 as an oncogene in papillary thyroid carcinoma. Tumour Biol 34(3):1635–1639

Zhao HD, Tang HL, Liu NN, Zhao YL, Liu QQ, Zhu XS, Jia LT, Gao CF, Yang AG, Li JT (2016) Targeting ubiquitin-specific protease 22 suppresses growth and metastasis of anaplastic thyroid carcinoma. Oncotarget 7(21):31191–31203

Zhao H, Tang H, Huang Q, Qiu B, Liu X, Fan D, Gong L, Guo H, Chen C, Lei S, Yang L, Lu J, Bao G (2016) MiR-101 targets USP22 to inhibit the tumorigenesis of papillary thyroid carcinoma. Am J Cancer Res 6(11):2575–2586

Wu W, Zhang L, Lin J, Huang H, Shi B, Lin X, Huang Z, Wang C, Qiu J, Wei X (2016) Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma. Oncotarget 7(51):84416–84427

Herranz D, Maraver A, Canamero M, Gomez-Lopez G, Inglada-Perez L, Robledo M, Castelblanco E, Matias-Guiu X, Serrano M (2013) SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene 32(34):4052–4056

Xu G, Cai J, Wang L, Jiang L, Huang J, Hu R, Ding F (2018) MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling. Exp Cell Res 362(2):268–278

Marlow LA, von Roemeling CA, Cooper SJ, Zhang Y, Rohl SD, Arora S, Gonzales IM, Azorsa DO, Reddi HV, Tun HW, Doppler HR, Storz P, Smallridge RC, Copland JA (2012) Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategies. J Cell Sci 125(Pt 18):4253–4263

Roehlen N, Doering C, Hansmann ML, Gruenwald F, Vorlaender C, Bechstein WO, Holzer K, Badenhoop K, Penna-Martinez M (2018) Vitamin D, FOXO3a, and Sirtuin1 in Hashimoto’s Thyroiditis and differentiated thyroid Cancer. Front Endocrinol (Lausanne) 9527

Yang J, Zhao X, Tang M, Li L, Lei Y, Cheng P, Guo W, Zheng Y, Wang W, Luo N, Peng Y, Tong A, Wei Y, Nie C, Yuan Z (2017) The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells. Oncotarget 8(14):23492–23506

Panda PK, Naik PP, Meher BR, Das DN, Mukhopadhyay S, Praharaj PP, Maiti TK, Bhutia SK (2018) PUMA dependent mitophagy by Abrus agglutinin contributes to apoptosis through ceramide generation. Biochim Biophys Acta Mol Cell Res 1865(3):480–495

Dey P, Strom A, Gustafsson JA (2014) Estrogen receptor beta upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. Oncogene 33(33):4213–4225

Ling S, Li J, Shan Q, Dai H, Lu D, Wen X, Song P, Xie H, Zhou L, Liu J, Xu X, Zheng S (2017) USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Mol Oncol 11(6):682–695

Zhao X, Liu Y, Zhu G, Liang Y, Liu B, Wu Y, Han M, Sun W, Han Y, Chen G, Jiang J (2019) SIRT1 downregulation mediated manganese-induced neuronal apoptosis through activation of FOXO3a-Bim/PUMA axis. Sci Total Environ 6461047–1055

Yin Q, Liu S, Dong A, Mi X, Hao F, Zhang K (2016) Targeting transforming growth Factor-Beta1 (TGF-beta1) inhibits tumorigenesis of anaplastic thyroid carcinoma cells through ERK1/2-NFkappakB-PUMA signaling. Med Sci Monit 222267–2277

Khani P, Nasri F, Khani Chamani F, Saeidi F, Sadri Nahand J, Tabibkhooei A, Mirzaei H (2019) Genetic and epigenetic contribution to astrocytic gliomas pathogenesis. J Neurochem 148(2):188–203

Dashti F, Mirazimi SMA, Rabiei N, Fathazam R, Rabiei N, Piroozmand H, Vosough M, Rahimian N, Hamblin MR, Mirzaei H (2021) The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Mol Ther Nucleic Acids 26:892–926

Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M (2017) MicroRNA-based molecular classification of papillary thyroid carcinoma. Int J Oncol 50(5):1767–1777

Zhang Y, Pan J, Xu D, Yang Z, Sun J, Sun L, Wu Y, Qiao H (2018) Combination of serum microRNAs and ultrasound profile as predictive biomarkers of diagnosis and prognosis for papillary thyroid microcarcinoma. Oncol Rep 40(6):3611–3624

Wu Y, Zhang J, Hou S, Cheng Z, Yuan M (2017) Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB. Biotechnol Lett 39(12):1827–1834

Xie R, Wu SN, Gao CC, Yang XZ, Wang HG, Zhang JL, Yan W, Ma TH (2017) MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the posttranscriptional regulation of enhancer of zeste homolog 2. Oncol Rep 37(3):1682–1690

Yan L, Qiu J, Yao J (2017) Downregulation of microRNA-30d promotes cell proliferation and invasion by targeting LRH-1 in colorectal carcinoma. Int J Mol Med 39(6):1371–1380

Zhang R, Xu J, Zhao J, Bai J (2017) Mir-30d suppresses cell proliferation of colon cancer cells by inhibiting cell autophagy and promoting cell apoptosis. Tumour Biol 39(6):1010428317703984

Esposito F, Tornincasa M, Pallante P, Federico A, Borbone E, Pierantoni GM, Fusco A (2012) Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 97(5):E710–718

Natalino RJ, Antoneli CB, Ribeiro KC, Campos AH, Soares FA (2016) Immunohistochemistry of apoptosis-related proteins in retinoblastoma. Pathol Res Pract 212(12):1144–1150

Qiu XG, Chen YD, Yuan J, Zhang N, Lei T, Liu J, Yang M (2019) Functional BCL-2 rs2279115 promoter noncoding variant contributes to Glioma Predisposition, especially in males. DNA Cell Biol 38(1):85–90

Koga T, Suico MA, Shimasaki S, Watanabe E, Kai Y, Koyama K, Omachi K, Morino-Koga S, Sato T, Shuto T, Mori K, Hino S, Nakao M, Kai H (2015) Endoplasmic reticulum (ER) stress induces sirtuin 1 (SIRT1) expression via the PI3K-Akt-GSK3beta signaling pathway and promotes Hepatocellular Injury. J Biol Chem 290(51):30366–30374

Liang Q, Dexheimer TS, Zhang P, Rosenthal AS, Villamil MA, You C, Zhang Q, Chen J, Ott CA, Sun H, Luci DK, Yuan B, Simeonov A, Jadhav A, Xiao H, Wang Y, Maloney DJ, Zhuang Z (2014) A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. Nat Chem Biol 10(4):298–304

Peng L, Yuan Z, Li Y, Ling H, Izumi V, Fang B, Fukasawa K, Koomen J, Chen J, Seto E (2015) Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival. J Biol Chem 290(14):8904–8912

Li D, Bai L, Wang T, Xie Q, Chen M, Fu Y, Wen Q (2018) Function of miR-212 as a tumor suppressor in thyroid cancer by targeting SIRT1. Oncol Rep 39(2):695–702

Li X, Liu K, Zhou W, Jiang Z (2020) MiR-155 targeting FoxO3a regulates oral cancer cell proliferation, apoptosis, and DDP resistance through targeting FoxO3a. Cancer Biomark 27(1):105–111

Wang YQ, Cao Q, Wang F, Huang LY, Sang TT, Liu F, Chen SY (2015) SIRT1 protects against oxidative Stress-Induced endothelial progenitor cells apoptosis by inhibiting FOXO3a via FOXO3a ubiquitination and degradation. J Cell Physiol 230(9):2098–2107

An BS, Tavera-Mendoza LE, Dimitrov V, Wang X, Calderon MR, Wang HJ, White JH (2010) Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor. Mol Cell Biol 30(20):4890–4900

Sun L, Huang Y, Liu Y, Zhao Y, He X, Zhang L, Wang F, Zhang Y (2018) Ipatasertib, a novel akt inhibitor, induces transcription factor FoxO3a and NF-kappaB directly regulates PUMA-dependent apoptosis. Cell Death Dis 9(9):911

Pan Y, Liu P, Chen D, Dou L (2017) Small interfering RNA (siRNA) against slug induces apoptosis and sensitizes human anaplastic thyroid carcinoma cells to doxorubicin. Cancer Biomark 18(4):357–366